Press Releases

Mithra Pharmaceuticals Invests EUR 75.2 Million in Flemalle
17 November 2015
EN FR NL

Mithra Pharmaceuticals Selects Chiltern as CRO for the Phase II Clinical Trials of its Product Candidate Donesta®
21 October 2015
EN FR

Mithra Pharmaceuticals Announces Strengthening of its Management Team
1 October 2015
EN FR

New Market Share Record for Mithra Pharmaceuticals in August 2015
30 September 2015
EN FR

Half Year 2015 Results ( Full report )
4 September 2015
EN FR

Mithra Pharmaceuticals Announces its First Half 2015 Financial Results and Operational Progress
4 September 2015
EN FR

The European Journal of Contraception and Reproductive Health Care Publishes Two Scienfitic Articles About E4 (Estetrol) Dinox Phase II Study: Two Of The Most Read Papers By The Scientific Community
26 August 2015
EN FR

Mithra Pharmaceuticals SA reçoit l’autorisation de lancer son étude d’interaction alimentaire MIT-ES0001-C101
14 August 2015
EN FR

Exercise Overallotment Warrant Denominator
7 August 2015
EN FR NL

Exercise of the Over-allotment Option and End of the Stabilisation Period in Relation to the Initial Public Offering
30 July 2015
EN FR NL

Mithra Pharmaceuticals SA/NV Announces That it Grew to Record Market Share in Contraception in Belgium
17 July 2015
EN FR NL

Mithra Pharmaceuticals SA/NV Announces a Positive Evolution of the On-going Pharmacodynamics Studies for its Three-month Implant Zoreline®
17 July 2015
EN FR NL